DuPont Nutrition & Health divests alginates business to JRS 28th May 2018
DuPont Nutrition & Health has announced that it will divest its alginates business to Germany-based functional ingredients firm JRS Group.
This sale was a requirement established by the European Commission following DuPont’s acquisition of FMC’s Health and Nutrition business in 2017. It includes the heritage DuPont Nutrition & Health alginates business, the portfolio of pectin-alginate blends, the business’s Landerneau production facility and the company’s customers. The transaction is expected to close in Q3 2018.
Matthias Heinzel, DuPont N&H business president said: “The receipt of regulatory approval to divest the heritage DuPont N&H Alginates business is an important step in finalizing our integration of FMC’s Health & Nutrition Business.”
Josef Otto Rettenmaier, President of JRS Group added: “The receipt of regulatory approval from the EU Commission to acquire DuPont’s Alginate business is another milestone in strengthening the Life Science Division of JRS Group. We are continuously complementing our broad product portfolio to develop innovative solutions for our global customers. JRS focusses on ‘Green Products’ made of renewable, botanical resources. Therefore, alginates perfectly fit our product portfolio of excipients and hydrocolloids for pharma, food and personal care applications.”